180741-45-1 Usage
Description
(4-CHLORO-5-METHYL-PYRAZOL-1-YL)-ACETIC ACID is a chemical compound with a molecular formula C7H8ClN2O2, derived from pyrazole. It is recognized for its antimicrobial properties and potential applications in the development of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
(4-CHLORO-5-METHYL-PYRAZOL-1-YL)-ACETIC ACID is used as an intermediate in the synthesis of various pharmaceuticals for its ability to inhibit the growth of certain bacterial and fungal strains. This makes it a valuable component in the development of antimicrobial agents.
Used in Agrochemical Industry:
In the agrochemical industry, (4-CHLORO-5-METHYL-PYRAZOL-1-YL)-ACETIC ACID is used as a starting material for the creation of compounds that can protect crops from diseases caused by bacteria and fungi, thus enhancing crop yield and quality.
Used in Anti-Inflammatory and Analgesic Applications:
(4-CHLORO-5-METHYL-PYRAZOL-1-YL)-ACETIC ACID has been studied for its potential anti-inflammatory and analgesic properties, making it a candidate for the treatment of pain and inflammation-related conditions. Its use in this application could lead to the development of new medications for various medical conditions.
Overall, (4-CHLORO-5-METHYL-PYRAZOL-1-YL)-ACETIC ACID is a versatile chemical with potential uses in various fields, including medicine and agriculture, due to its antimicrobial, anti-inflammatory, and analgesic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 180741-45-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,7,4 and 1 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 180741-45:
(8*1)+(7*8)+(6*0)+(5*7)+(4*4)+(3*1)+(2*4)+(1*5)=131
131 % 10 = 1
So 180741-45-1 is a valid CAS Registry Number.
180741-45-1Relevant articles and documents
ANTAGONISTS OF CHEMOKINE RECEPTORS
-
Paragraph 0237; 0238, (2014/03/24)
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
